Omikenshi Co., Ltd.
Omikenshi Co., Ltd. (3111.T) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Omikenshi Co., Ltd. (3111.T), covering cash flow, earnings, and balance sheets.
Omikenshi Co., Ltd. (3111.T) Income Statement & Financial Overview
Explore comprehensive income reports for Omikenshi Co., Ltd. 3111.T, broken down by year and quarter.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $996.00M | $746.00M | $781.00M | $884.00M |
Cost of Revenue | $588.00M | $462.00M | $476.00M | $495.00M |
Gross Profit | $408.00M | $284.00M | $305.00M | $389.00M |
Gross Profit Ratio | $0.41 | $0.38 | $0.39 | $0.44 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $277.00M | $280.00M | $309.00M | $283.00M |
Operating Expenses | $277.00M | $281.00M | $308.00M | $284.00M |
Total Costs & Expenses | $865.00M | $743.00M | $784.00M | $779.00M |
Interest Income | $0.00 | $0.00 | $0.00 | $55.00M |
Interest Expense | $48.00M | $48.00M | $56.00M | $0.00 |
Depreciation & Amortization | $18.00M | $9.00M | $12.00M | $10.00M |
EBITDA | -$56.00M | $13.00M | $7.00M | $115.00M |
EBITDA Ratio | -$0.06 | $0.02 | $0.009 | $0.13 |
Operating Income | $131.00M | $3.00M | -$3.00M | $105.00M |
Operating Income Ratio | $0.13 | $0.004 | -$0.004 | $0.12 |
Other Income/Expenses (Net) | -$254.00M | -$32.00M | $665.00M | -$222.00M |
Income Before Tax | -$123.00M | -$29.00M | $662.00M | -$117.00M |
Income Before Tax Ratio | -$0.12 | -$0.04 | $0.85 | -$0.13 |
Income Tax Expense | $6.00M | $2.00M | $85.00M | -$1.00M |
Net Income | -$129.00M | -$31.00M | $577.00M | -$117.00M |
Net Income Ratio | -$0.13 | -$0.04 | $0.74 | -$0.13 |
EPS | -$19.55 | -$2.51 | $60.23 | -$17.74 |
Diluted EPS | -$19.55 | -$3.03 | $60.23 | -$17.74 |
Weighted Avg Shares Outstanding | $6.60M | $7.97M | $6.60M | $6.60M |
Weighted Avg Shares Outstanding (Diluted) | $6.60M | $6.60M | $9.40M | $6.60M |
Over the past four quarters, Omikenshi Co., Ltd. demonstrated steady revenue growth, increasing from $884.00M in Q1 2024 to $996.00M in Q4 2024. Operating income reached $131.00M in Q4 2024, maintaining a consistent 13% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$56.00M, reflecting operational efficiency. Net income dropped to -$129.00M, with EPS at -$19.55. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan